Skip to main content

A roundup of some of the North American equities making moves in both directions today

Hudsons Bay Co. (HBC-T) rose almost 21 per cent on Tuesday following a report that chairman Richard Baker is considering raising his bid for the retailer to almost $11 per share.

Shares were briefly halted Tuesday morning on the Toronto Stock Exchange after volatile trading activity triggered a regulatory safety mechanism.

Story continues below advertisement

The trading halt was issued at 9:52 a.m. ET as a result of a single-stock circuit breaker, which is enacted in order to ensure fairness in the market, according to the Investment Industry Regulatory Organization of Canada.

HBC shares opened at $8.38 and quickly shot to $10.09, a gain of more than 22 per cent, before falling back to $9.40.

The company’s shares resumed trading at 9:57 a.m., and were at $9.52 in midmorning trading.

See also: OSC issues order on HBC privatization bid; no vote until new year, if Baker decides to proceed

Why the value of Saks Fifth Avenue flagship store dropped by billions – and what it means to the fate of HBC

Shares of B.C.-based Neovasc Inc. (NVCN-T) jumped over 38 per cent after the medical device company announced the submission of a Premarket Approval application (PMA) to the U.S. Food and Drug Administration for its Neovasc Reducer medical device for the treatment of refractory angina.

Neovasc said the submission also includes a request for an Advisory Panel meeting.

Story continues below advertisement

“This submission marks an important milestone in our effort to bring Reducer to the U.S. market, where it is estimated that there are up to 1.8 million patients with refractory angina,” said president and CEO Fred Colen. “These patients have traditionally had no options - they are either unsuitable for revascularization or continue to suffer with angina following revascularization procedures. The Reducer provides potential relief of angina symptoms by altering blood flow within the myocardium of the heart and increasing the perfusion of oxygenated blood to ischemic areas of the heart muscle.”

Bombardier Inc. (BBD-B-T) closed flat on the announcement that Paris-based Latécoère will acquire its electrical wiring interconnection system (EWIS) assets in Querétaro, Mexico for US$50-million.

The companies also secured a long-term supply agreement that will see Latécoère supply Bombardier with electrical wiring interconnection systems.

“The transaction further supports Bombardier Aviation’s transformation and sharpens the company’s focus on its core manufacturing capabilities,” the company said in a release. “The skilled employees who manufacture the main harnesses and electrical subassemblies in Querétaro will bring years of experience and value to Latécoère. The sale will not impact the remainder of Bombardier’s operations at its Querétaro site, which will continue to produce major structures for Bombardier aircraft, such as the aft fuselage for the Global family of business aircraft – including the company’s flagship Global 7500 jet – the most complex aircraft component manufactured in Mexico.”

Just Energy Group Inc. (JE-T) was up 8.5 per cent following the premarket announcement of the sale of its customer contracts and natural gas in storage in the state of Georgia to Infinite Energy for approximately $4.4-million.

“The Georgia market has limited growth possibility and was sub-scale for Just Energy,” it said in a statement.

Story continues below advertisement

In addition, the Toronto-based company also announced it has closed the sale of its Irish operations to Flogas Natural Gas Limited for approximately $1.0 million.

"The sale of our Georgia based assets and operations in Ireland, in addition to the earlier sale of our UK operations, are key milestones in our strategy to refine our focus,” said president and CEO Scott Gahn. “These changes to our business structure allow us to concentrate on our stronger growth and higher-margin operations in North America, while reducing costs.”

EnWave Corp. (ENW-X) increased 14.3 per cent after announcing it has signed an Equipment Purchase Agreement for the delivery of a 100kW nutraREV processing line to Consulting FB Tech and Apps S.L. (“Fresh Business”) in Peru.

The Vancouver-based company signed a royalty-bearing commercial license agreement with Fresh Business in April.

U.S-listed shares of Tencent Music Entertainment (TME-N) rose 0.7 per cent after a consortium led by the China-based company agreed to buy a 10-per-cent stake in Vivendi’s Universal Music Group.

The deal allows both companies to expand in a recovering global music market, giving Tencent more access to U.S. artists while UMG can tap into the Asian market, including big-selling “K-Pop” Korean pop stars.

Story continues below advertisement

After months of talks, French media conglomerate Vivendi said on Tuesday it had finalized the sale of an initial 10 per cent of the world’s largest music label to the Tencent consortium, which also had the option to buy up to 10 per cent more by January 2021 on the same price basis.

Vancouver-based Emerald Health Therapeutics Inc. (EMH-X) was up 1.6 per cent after announcing it has closed the initial tranche of a private placement.

The cannabis company said gross proceeds of the previously announced non-brokered placement, in which it issued 5,172,942 units at 29 cents each, was $1,500,153.

All units sold were purchased by Emerald Health Sciences Inc., a control person of Emerald, and certain directors and officers of Emerald.

On the decline

A day after jumping almost 15 per cent, shares of Maxar Technologies Inc. (MAXR-T) were down 5.3 per cent in the wake of the announcement it’s set to sell its Canadian space robotics business to a consortium led by Northern Private Capital for $1-billion.

In response to the deal, an equity analyst at Raymond James lowered his rating for Maxar shares.

Story continues below advertisement

With files from staff and wires

Related topics

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies